Jaguar Health to complete 1-for-15 reverse stock split on September 17, 2026

Jaguar Health, Inc. (Nasdaq: JAGX) disclosed in an 8-K filed with the SEC that it will carry out a 1-for-15 reverse stock split of its common stock effective September 17, 2026. The company said the split is designed to help it meet Nasdaq's listing requirements.¹

The action follows stockholder approval at Jaguar's April 2026 special meeting. At that meeting, held April 20, 2026, stockholders approved a Twelfth Amendment to the company's certificate of incorporation authorizing a reverse split at a ratio the board could set anywhere between 1-for-15 and 1-for-150, with the board required to choose the final ratio by April 20, 2027.¹ The board settled on a one-for-fifteen ratio, and the company filed the Twelfth Amendment with the Delaware Secretary of State on September 14, 2026.¹

The split becomes effective at 12:01 am Eastern Time on September 17, 2026, at which point every fifteen shares of common stock outstanding will be automatically converted into one share, with no change to par value.¹ The split will also proportionately reduce shares issuable under outstanding stock options and warrants while increasing their exercise prices, proportionately reduce shares reserved under equity compensation plans, and it does not change the company's total authorized share count for common or preferred stock.¹

No fractional shares will be issued; holders otherwise entitled to a fractional share will instead receive a cash payment.¹ Equiniti Trust Company, LLC is serving as exchange agent for the transaction.¹ The stock's new CUSIP number following the split is 47010C854.¹ Trading will continue on The Nasdaq Capital Market under the ticker JAGX on a split-adjusted basis starting September 17, 2026.¹